Claritas Pharmac Stock Price, News & Analysis
Company Description
Claritas Pharmac (OTC Link: CLAZF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $664.7K.
CLAZF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of CLAZF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Claritas Pharmac (CLAZF) stock last traded at $0.0000. At a market capitalization of $664.7K, CLAZF is classified as a micro-cap stock with approximately 37.8M shares outstanding.
Latest News
Claritas Pharmac has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all CLAZF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CLAZF Company Profile & Sector Positioning
Claritas Pharmac (CLAZF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CLAZF often look at related companies in the same sector, including Emmaus Life Scie (EMMA), Lobe Sciences (LOBEF), Regen Biopharma (RGBP), Hepion Pharmaceuticals Inc (HEPA), and Anthera Pharmace (ANTH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLAZF's relative position within its industry.